Skip to content
Evigrade
CriticalMacrolide antibiotic×Atypical antipsychotics

Updated · Methodology

Mechanism

The liver metabolises quetiapine mainly through the enzyme CYP3A4. Ketoconazole, a CYP3A4 inhibitor, increased the quetiapine area under the concentration curve (AUC) 5- to 8-fold (quetiapine summary of product characteristics, SmPC, Spanish Agency of Medicines and Medical Devices, AEMPS). Erythromycin inhibits CYP3A4 and the transporter P-glycoprotein, moderately according to its Spanish SmPC (erythromycin SmPC, AEMPS). The Spanish quetiapine SmPC names erythromycin among the CYP3A4 inhibitors that are contraindicated with quetiapine (AEMPS). The documents do not say how much erythromycin raises quetiapine levels. The second mechanism involves the QT interval. Post-marketing reports describe QT prolongation with quetiapine at therapeutic doses and in overdose, and QT prolongation with a risk of torsade de pointes has been observed during erythromycin treatment (quetiapine and erythromycin SmPCs, AEMPS).

Symptoms

The documents do not describe what higher quetiapine levels with erythromycin would cause. The most common adverse effects of quetiapine include drowsiness, dizziness and dry mouth, and a drop in blood pressure when standing up, with dizziness, can lead to falls, especially in older people (quetiapine summary of product characteristics, SmPC, Spanish Agency of Medicines and Medical Devices, AEMPS). An overdose of quetiapine exaggerates its known effects: drowsiness and sedation, a fast heart rate, low blood pressure and anticholinergic effects. QT prolongation, seizures, respiratory depression, confusion, coma and death can also occur (AEMPS). Rare effects of erythromycin include QT prolongation, ventricular tachyarrhythmia, palpitations and torsade de pointes (erythromycin SmPC, AEMPS).

Management

The combination is contraindicated. The Spanish quetiapine summary of product characteristics (SmPC) contraindicates quetiapine with inhibitors of the enzyme CYP3A4 and names erythromycin (quetiapine SmPC, Spanish Agency of Medicines and Medical Devices, AEMPS). The US quetiapine label says to avoid quetiapine with drugs known to prolong the QTc interval, including antibiotics with this effect (quetiapine label, US Food and Drug Administration, FDA). The erythromycin documents do not name quetiapine. They advise caution when erythromycin is given to people taking other QT-prolonging drugs and close monitoring of the levels of drugs metabolised by cytochrome P450 enzymes (erythromycin SmPC, AEMPS). The Spanish SmPC of one intravenous generic erythromycin contraindicates erythromycin with certain QT-prolonging neuroleptics. The SmPCs of the original erythromycin products do not (erythromycin SmPCs, AEMPS). Erythromycin must not be given to people with a history of QT prolongation or ventricular arrhythmia or with low potassium or magnesium (AEMPS). Use quetiapine with caution in cardiovascular disease, a family history of QT prolongation, congenital long QT syndrome, heart failure, cardiac hypertrophy and low potassium or magnesium, especially in older people (quetiapine SmPC, AEMPS). The documents give no interval between stopping erythromycin and starting quetiapine. The half-life is about 2 hours for erythromycin, about 7 hours for quetiapine and about 12 hours for its active metabolite norquetiapine (erythromycin and quetiapine SmPCs, AEMPS). If signs of quetiapine overdose appear, support breathing and circulation with cardiac monitoring. Treat persistent low blood pressure with intravenous fluids or sympathomimetics, but not adrenaline or dopamine (quetiapine SmPC, AEMPS, overdose section).

Your whole list in one report

Up to 15 drugs: every pair in one table and a PDF report. Your first report is free: we only ask for your email

Add more drugs

Medicine list: everything you take in one place →

Sources

Other interactions with Erythromycin

Other interactions with Quetiapine